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Implantation of an Endoluminal Prosthesis at the Distal 
Anastomosis of a Bypass Graft for Abrupt Closure 
Following Balloon Angioplasty 
B.H. Strauss, MD, 0. Leborgne, MD, I.K. De Scheerder, MD, Ph.D, 
and P.W. Serruys, MD, Ph.D 
A coronary Walktent@ was implanted in a 10-year-old saphenous vein bypass graft fol- 
lowing a PTCA that was complicated by abrupt closure. Anterograde flow was restored 
and no myocardial necrosis resulted. One week later, bypass surgery was performed due 
to a bleeding compllcatlon associated with the anticoagulation regimen. 
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INTRODUCTION 
Abrupt closure during angioplasty is usually an unher- 
alded event with potentially catastrophic effects. Several 
studies have shown that this complication of PTCA oc- 
curs in 2-4% of procedures and is associated with a 43% 
myocardial infarction rate and necessitates bypass oper- 
ation in 1/3 of patients [ 1,2]. Several pathophysiologic 
processes that contribute to occlusion have been identi- 
fied, including extensive medial dissection and the for- 
mation of intimal flaps, superimposed vasospasm, and 
possibly thrombus deposition. In this case report we de- 
scribe successful treatment of abrupt closure in a saphe- 
nous vein bypass graft by the placement of a mechanical 
stent at the junction of the vein graft and native coronary 
artery. 
CASE REPORT 
A 64-year-old man underwent coronary artery bypass 
grafting to the left anterior descending artery (LAD) and 
the first diagnonal branch in 1977 for unstable angina 
pectoris. The patient remained asymptomatic for 10 
years when he was admitted to hospital for recurrent 
anginal episodes associated with ST segment depression 
at rest. Angiography showed progression of disease in 
the native vessels, including an occluded LAD as well as 
two serial narrowings in the distal part of the LAD graft. 
A PTCA of the graft stenosis was successfully performed 
and the patient was discharged 1 week later. 
Three weeks after discharge, the patient was readmit- 
ted for unstable angina. At coronary angiography, an 
early restenosis of the LAD graft was found, and a sec- 
ond PTCA was attempted (Fig. lA,B). After inflation 
with a 2.5 mm balloon, a luminal irregularity was seen, 
suggesting an intimal flap or possibly disruption of a 
friable atherosclerotic plaque. Following redilatation 
with a 3 mm balloon, the patient experienced severe 
chest pain associated with new ST segment elevation. 
The angiogram now showed a large intraluminal defect 
(Fig. 1C). Therefore, the decision was taken to immedi- 
ately implant an endoluminal stent (Wallstento, Medin- 
vent, Lausanne, Switzerland) according to a protocol ap- 
proved by our Institutional Review Board. The stent was 
properly deployed at the distal anastomotic site and was 
visible proximally in the graft and distally in the native 
LAD (Fig. 1D). The restoration of brisk anterograde 
flow was accompanied by resolution of the chest pain 
and electrocardiographic changes. 
The anticoagulation regimen was initiated before 
stenting with the infusion of heparin 10,000 units i.v. 
and aspirin 250 mg i.v. (which was continued poststent- 
ing at a daily oral dose of 250 mg). During the stent 
implantation, urokinase 500,000 IU intracoronary and an 
additional 10,000 units of heparin i.v. were given and 
followed by a continuous heparin infusion (30,000 units/ 
24 h) that was titrated to maintain an activated partial 
thromboplastin time between 120 and 180 s. An oral 
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Fig. 1. A: Lesion prior to dilatation. 6: During balloon inflation. C: Intermediate result with the 
intraluminal defect. D: Final result after stenting. 
vitamin K antagonist, acenocoumarol, was prescribed 
daily starting the day of implantation to maintain the 
Thrombotest@' (Nycomed, Oslo, Norway) between 5% 
and 10% of control activity for 2 consecutive days at 
which time the heparin was slowly discontinued. The 
Thrombotest@ is a modified prothrombin time assay that 
is sensitive for reduced levels of coagulation factors 11, 
VII, and X and the presence of PIVKA (protein induced 
by vitamin K absence or antagonists) that result from 
anticoagulation therapy. An angiogram at 24 h con- 
firmed stent patency and absence of the previously ob- 
served intraluminal defect (Fig. 2A). Cardiac enzymes 
were not elevated over the next 72 h, and the patient 
remained stable. 
One week later, while the Thrombotest@ was within 
the therapeutic range, the patient suffered an upper gas- 
trointestinal bleed secondary to a Mallory-Weiss tear. 
The anticoagulation therapy was initially reduced, and 
later discontinued because of continued bleeding. Sub- 
sequently the chest pain and ECG changes recurred and 
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Fig. 2. A: Control coronary angiogram 24 hours afler stenting. B: Afler discontinuing the antico- 
agulation therapy, a thrombus (see arrow) Is visible in the proximal segment of the native LAD. 
angiography now showed a thrombus in the proximal 
segment of the native LAD that was attached to the pros- 
thesis by a small pedicle, although distal flow was main- 
tained (Fig. 2B). Due to the unstable situation and the 
contraindication to anticoagulation, the patient was sent 
for bypass surgery from which he recovered unevent- 
fully. 
DISCUSSION 
Previous studies have indicated that there is significant 
atherosclerotic narrowing (>50% diameter stenosis) in 
about 1/3 of saphenous vein bypass grafts that are patent 
at 10 years [3,4]. Repeat operation is generally less ef- 
fective and associated with an increased risk compared to 
the first procedure [ 5 ] .  PTCA has been investigated as an 
alternative to surgery for the treatment of saphenous vein 
graft stenosis. Although primary success rates of PTCA 
of bypass grafts range from 78 to 93% [6], it is limited by 
a high restenosis rate (up to 50% at the proximal anas- 
tomosis) within 6 months of the angioplasty [7] in addi- 
tion to the acute complications of occlusion and distal 
embolization. Although the effect of endovascular de- 
vices on diminishing the late restenosis rate is currently 
unknown, this case confirms the finding of one other 
clinical report (restricted to native vessels) that coronary 
stenting may be an effective bail-out technique in abrupt 
closure situation [8]. 
Saphenous vein bypass grafts in particular have sev- 
eral features that favour the use of stents either as an 
alternative or an adjunct to PTCA. Atheromatous 
plaques in saphenous vein bypass grafts often contain an 
abundant amount of cholesterol crystals and necrotic de- 
bris and tend to be softer and more friable than native 
coronary artery lesions. Pathologic studies have shown 
that PTCA may induce extensive disruption of these fri- 
able plaques, resulting in abrupt closure or distal embo- 
lization [9]. This particular stent may act as a splint to 
contain these protruding lesions as well as limit the elas- 
tic recoil that can contribute to abrupt closure and early 
restenosis. Saphenous vein grafts also tend to be larger 
than native coronary arteries and better suited to implan- 
tation of larger prostheses (>3  mm) that are less likely to 
thrombose. The optimal strategy following a bail-out 
stent (elective surgery or long-term anticoagulation) re- 
mains unknown. This case illustrates the hazards of the 
long-term anticoagulation required with the currently in- 
vestigated stents. Intensive regimens that include hepa- 
rin, aspirin, and urokinase during the procedure, fol- 
lowed by at least 6 months of warfarin and aspirin, 
require careful patient selection and close monitoring. 
Thrombotic events have occurred in several cases when 
this schedule has been interrupted, even if only for brief 
periods of time. 
Coronary stenting in saphenous vein bypass grafts has 
thus far only been investigated with the Medinvent stent 
[lo]. As of February 1990, a total of 156 WallstentsO 
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have been implanted in the bypass grafts of 85 patients. 
Firm clinical indications for implantation of coronary 
stents in bypass grafts however must await the outcome 
of randomized trials. 
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